iLIVER

Open Access Short Communication

Tumor-immune Co-evolution in hepatocellular carcinoma and its implication for immunotherapy resistance

Zhiyuan Fang, Huayu Yang, Yilei Mao

https://doi.org/10.1016/j.iliver.2022.02.003

Published: 09 March 2022

2022, 1 (1): 78-80

Downloads: 229 | Views: 929 |

PDF (249.2 KB)

Open Access Review

The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease

Xinhe Zhang, Haoyu Tian, Yiling Li

https://doi.org/10.1016/j.iliver.2022.02.004

Published: 10 March 2022

2022, 1 (1): 65-71

Downloads: 141 | Views: 964 |

PDF (600.6 KB)

Open Access Review

Perihilar cholangiocarcinoma: a surgeon's perspective

Masato Nagino

https://doi.org/10.1016/j.iliver.2022.03.004

Published: 05 April 2022

2022, 1 (1): 12-24

Downloads: 130 | Views: 1232 |

PDF (2.7 MB)

Open Access Original Article

Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma

Ying Liu, Yaqin Wang, Zhanqi Wei, [...], Tianxiao Wang, Shizhong Yang, Canhong Xiang, Xuedong Wang, Lei Gong, Jiahong Dong, Qian Lu, Yuewei Zhang << Fewer

https://doi.org/10.1016/j.iliver.2022.01.001

Published: 07 March 2022

2022, 1 (1): 35-42

Downloads: 63 | Views: 1026 |

PDF (850.9 KB)

Open Access Original Article

Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?

Feng Gong, Kenneth I. Zheng, Liang-Jie Tang, [...], Gang Li, Rafael S. Rios, Ou-Yang Huang, Yang-Yang Li, Christopher D. Byrne, Giovanni Targher, Man Mi, Na He, Hong-Lei Ma, Ming-Hua Zheng << Fewer

https://doi.org/10.1016/j.iliver.2022.02.001

Published: 07 March 2022

2022, 1 (1): 30-34

Downloads: 48 | Views: 2123 |

PDF (445.2 KB)

Open Access Review

Liver transplantation for malignant liver tumors

Richard X. Sousa Da Silva, Beat Muellhaupt, Philipp Dutkowski, Pierre-Alain Clavien

https://doi.org/10.1016/j.iliver.2022.04.002

Published: 18 April 2022

2022, 1 (1): 3-11

Downloads: 38 | Views: 734 |

PDF (1.2 MB)

Open Access Original Article

Single-cell transcriptome analysis reveals a cancer-associated fibroblast marker gene signature in hepatocellular carcinoma that predicts prognosis

Hao Chi, Dapeng Chen, Yuliang Zhang, [...], Zilin Cui, Yi Bai, Yamin Zhang << Fewer

https://doi.org/10.1016/j.iliver.2022.12.002

Published: 13 January 2023

2023, 2 (1): 16-25

Downloads: 38 | Views: 296 |

PDF (4.1 MB)

Open Access Review

Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?

Xun Qiu, Fengqiang Gao, Kai Wang, [...], Zhensheng Zhang, Chuxiao Shao, Xiao Xu << Fewer

https://doi.org/10.1016/j.iliver.2022.03.003

Published: 28 March 2022

2022, 1 (1): 55-64

Downloads: 33 | Views: 761 |

PDF (1.6 MB)

Open Access Original Article

Associating liver partition and portal vein ligation for staged hepatectomy for colorectal liver metastasis: a single-center experience

Yuanfei Peng, Feiyu Chen, Zheng Wang, [...], Xiaoying Wang, Yinghong Shi, Zhenbing Ding, Yongsheng Xiao, Kang Song, Lei Yu, Jie Hu, Min Tang, Zhaoyou Tang, Jia Fan, Jian Zhou << Fewer

https://doi.org/10.1016/j.iliver.2022.02.002

Published: 09 March 2022

2022, 1 (1): 25-29

Downloads: 30 | Views: 631 |

PDF (306.1 KB)

Open Access Short Communication

Ascorbic acid ameliorates isoniazid-rifampicin-induced hepatocellular damage in rats

Shubham Patel, Aman Chaturvedi, Nazneen Dubey, [...], Abhishek Shrivastava, Aditya Ganeshpurkar << Fewer

https://doi.org/10.1016/j.iliver.2022.03.001

Published: 10 March 2022

2022, 1 (1): 72-77

Downloads: 29 | Views: 689 |

PDF (720.7 KB)